The rising
prevalence of infectious diseases and hospital-associated infections (HAI) that
can trigger sepsis, especially in the elderly population, newborn babies, and
people suffering from chronic ailments. For instance, in any developed country, 7 out of every 100
hospitalized patients probably develop hospital-acquired infections, while this
number is expected to rise to 10 in developing countries owing to its not so
well-maintained healthcare infrastructure, as per the WHO. Thus, with the rapid increase in HAIs across the
globe, there is a surging demand for effective sepsis diagnostic solutions.
Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18431
The recent COVID-19
pandemic has disrupted the healthcare industry with the emergence of SARS-COV-2
and the huge number of infected patients has significantly impacted the sepsis
diagnostics market. this is because of the increase in the number of patients
that are at a high risk of developing sepsis. Also, according to a recent study
among the non-survivors of COVID-19, almost 50% had a secondary infection, 100%
of these had sepsis, and about 70% had septic shock. Owing to this, there has
been an increasing demand for sepsis diagnostics solutions globally.
According to UnivDatos Market Insights (UMI)’ research
report “Global Sepsis Diagnostics Market Analysis,
2020”, the
sepsis diagnostics market is projected
to grow at a CAGR of around 9% during 2021-27F. Promulgating strategic
alliances is one of the prominent factors leading to the growth of the sepsis diagnostics market globally. For
example, in September 2020, Roche Diagnostics and Inotrem collaborated to
develop the sTREM-1 test, a diagnostic solution for sepsis.
Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18431
Based on the test type,
the market is fragmented into laboratory tests and point-of-care (POC) tests. The
laboratory tests segment accounted for a considerable share in 2020 and is
anticipated to register a lucrative CAGR during the forecast period. The growth
of this segment is attributed to the greater of laboratory testing in
comparison to POC testing while diagnosing sepsis. Also, the presence of
technologically advanced products in these laboratories has made the reliance
of the public and physicians on these labs which in turn is also boosting the
segment growth. However, POC testing is expected to grow significantly during
the forecast period owing to the new launches of rapid diagnosis assay kits in
the market.
Hospitals &
Specialty Clinics Segment to Witness Robust growth
Based on end-users, the market is segmented into
hospitals & specialty clinics, pathology & reference laboratories, and
others. The hospitals & specialty clinics segment had the highest revenue
and CAGR growth in the analyzed period as hospitals are the surge in the number
of patients hospitalization and presence of in-house diagnostic laboratories in
the hospital setting that performs a large number of blood culture tests.
For more informative
information, please visit us @ https://univdatos.com/report/sepsis-diagnostics-market/
North America to Grab
Lion’s Share, and Asia-Pacific witnessed Explicit Growth
Based on the region, North America dominated
the global sepsis diagnostics market
in 2020. The region is projected to maintain its dominance during the
forecasted period 2021-27 owing to the presence of well-established healthcare
infrastructure and growing adoption of advanced diagnostics systems in the region.
Asia-Pacific is expected to skyrocket with a CAGR of X% in the forecast period
owing, as stated in UnivDatos Market Insights (UMI)’
research report “Global Sepsis Diagnostics Market Analysis,
2020”.
According
to UnivDatos Market Insights (UMI)’,
the key players with a considerable market share in the Sepsis Diagnostics Market
include Danaher Corporation,
BioMérieux, Becton, Dickinson and Company, Roche Diagnostics, Thermo Fisher
Scientific, Abbott Laboratories, Luminex Corporation, T2 Biosystems, EKF
Diagnostics, Immunexpress, among
others. The players are focused on launching products for gaining customers'
traction and expanding their geographical reach to get a competitive edge in
the industry.
For more informative information, please visit us @ https://univdatos.com/report/sepsis-diagnostics-market/
“Global
Sepsis Diagnostics Market Analysis, 2020” provides comprehensive qualitative and
quantitative insights on the industry potential, key factors impacting sales
and purchase decisions, hotspots, and opportunities available for sepsis diagnostics providers across the Globe. Moreover,
the report also encompasses the key strategic imperatives for success for
competitors along with strategic factorial indexing measuring competitor's
capabilities on 16 parameters. This will help companies in the formulation of go
to Market Strategies and identifying the blue ocean for its offerings.
Market Segmentation:
1. By Technology
(Microbiology, Immunoassays, Molecular Diagnostics, and Flow Cytometry)
2. By Product (Blood
Culture Media, Assay & Reagents, Instruments, and Software)
3. By Pathogen (Bacterial,
Fungal, Viral, and Others)
4. By Test
Type (Laboratory Tests and Point-Of-Care (POC) Tests)
5. By
End-Users (Hospitals & Specialty Clinics, Pathology & Reference
Laboratories, and Others)
6.
By Region (North America,
Europe, Asia-Pacific, Rest of the World)
7.
By Company (Danaher Corporation, BioMérieux, Becton, Dickinson and Company, Roche
Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Luminex
Corporation, T2 Biosystems, EKF Diagnostics, Immunexpress, etc.)
Key
questions answered in the study:
1.
What are the current and future trends
of the sepsis diagnostics industry?
2.
How the industry has been evolving in
terms of technology, product, pathogen, test-type, and end-users?
3.
How the competition has been shaping
across the countries followed by their comparative factorial indexing?
4.
What are the key growth drivers and
challenges for the sepsis diagnostics industry?
5.
What is the customer orientation,
purchase behavior, and expectations from sepsis diagnostics firms across various regions?
Table
of Content –
1 MARKET INTRODUCTION
2 RESEARCH METHODOLOGY OR ASSUMPTION
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 COVID-19 IMPACT
6 GLOBAL SEPSIS DIAGNOSTICS MARKET REVENUE
7 MARKET INSIGHTS BY TECHNOLOGY
8 MARKET INSIGHTS BY PRODUCT
9 MARKET INSIGHTS BY PATHOGEN
10 MARKET INSIGHTS BY TEST TYPE
11 MARKET INSIGHTS BY END-USERS
12 MARKET INSIGHTS BY REGION
13 SEPSIS DIAGNOSTICS MARKET DYNAMICS
14 SEPSIS DIAGNOSTICS MARKET OPPORTUNITIES
15 SEPSIS DIAGNOSTICS MARKET TRENDS &
INSIGHTS
16 LEGAL & REGULATORY FRAMEWORK
17 DEMAND AND SUPPLY SIDE ANALYSIS
18 VALUE CHAIN ANALYSIS
19 COMPETITIVE SCENARIO
20 COMPANY PROFILED
21 DISCLAIMER
Browse Other Related Research Reports from UnivDatos
Market Insights
·
Ventilator
Market is expected to foresee steady growth by 2027|CAGR: 8%
·
Antiviral
Drugs Market is expected to grow at a steady pace by 2027 | CAGR: 3.4%
·
Diagnostics
Advancement along with several R&D investments Drives the Genomics Market
·
Cancer
Immunotherapy Market: Current Analysis and Forecast 2021-2027
Comments